In vitro and in vivo characterization of the new analgesic combination beta-caryophyllene and docosahexaenoic acid

Evidence-based Complementary and Alternative Medicine

Volumn 2014, Issue , 2014, Pages

  Fiorenzani, Paolo ^a   Lamponi, Stefania ^b   Magnani, Agnese ^b   Ceccarelli, Ilaria ^a   Aloisi, Anna Maria ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALMOND OIL; ANALGESIC AGENT; CARYOPHYLLENE; DOCOSAHEXAENOIC ACID; ESTRADIOL; TESTOSTERONE;

ACUTE TOXICITY; ANALGESIA; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG POTENTIATION; DRUG STABILITY; ESTRADIOL BLOOD LEVEL; FORMALIN TEST; IN VITRO STUDY; IN VIVO STUDY; LICKING; MALE; NONHUMAN; PAIN; RAT; TESTOSTERONE BLOOD LEVEL;

EID: 84904663213     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2014/596312     Document Type: Article

References (36)

1. Russo E. B., Cannabinoids in the management of difficult to treat pain. Therapeutics and Clinical Risk Management 2008 4 1 245 259 2-s2.0-41549121013 (Pubitemid 351460949)
2. Pergolizzi J., Aloisi A. M., Dahan A., Filitz J., Langford R., Likar R., Mercadante S., Morlion B., Raffa R. B., Sabatowski R., Sacerdote P., Torres L. M., Weinbroum A. A., Current knowledge of buprenorphine and its unique pharmacological profile. Pain Practice 2010 10 5 428 450 10.1111/j.1533-2500. 2010.00378.x 2-s2.0-78149491914
3. 2 receptors. Pharmacology and Therapeutics 1997 74 2 129 180 10.1016/S0163-7258(97)82001-3 2-s2.0-0030611978 (Pubitemid 27337346)
4. Mechoulam R., Fride E., Di Marzo V., Endocannabinoids. European Journal of Pharmacology 1998 359 1 1 18 10.1016/S0014-2999(98)00649-9 2-s2.0-0032538527 (Pubitemid 28515716)
5. 2 regulates bone mass. Proceedings of the National Academy of Sciences of the United States of America 2006 103 3 696 701 10.1073/pnas.0504187103 2-s2.0-31444437185 (Pubitemid 43153088)
6. Galve-Roperh I., Aguado T., Rueda D., Velasco G., Guzmán M., Endocannabinoids: a new family of lipid mediators involved in the regulation of neural cell development. Current Pharmaceutical Design 2006 12 18 2319 2325 10.2174/138161206777585139 2-s2.0-33745164608 (Pubitemid 43891402)
7. 2 receptor activation decreases cerebral infarction in a mouse focal ischemia/reperfusion model. Journal of Cerebral Blood Flow and Metabolism 2007 27 7 1387 1396 10.1038/sj.jcbfm.9600447 2-s2.0-34250717998 (Pubitemid 46985356)
8. Ni X., Geller E. B., Eppihimer M. J., Eisenstein T. K., Adler M. W., Tuma R. F., Win 55212-2, a cannabinoid receptor agonist, attenuates leukocyte/endothelial interactions in an experimental autoimmune encephalomyelitis model. Multiple Sclerosis 2004 10 2 158 164 10.1191/1352458504ms1009oa 2-s2.0-16544377251 (Pubitemid 38499908)
9. Xu H., Cheng C. L., Chen M., Manivannan A., Cabay L., Pertwee R. G., Coutts A., Forrester J. V., Anti-inflammatory property of the cannabinoid receptor-2-selective agonist JWH-133 in a rodent model of autoimmune uveoretinitis. Journal of Leukocyte Biology 2007 82 3 532 541 10.1189/jlb.0307159 2-s2.0-34548446421 (Pubitemid 47367143)
10. Walter L., Stella N., Cannabinoids and neuroinflammation. The British Journal of Pharmacology 2004 141 5 775 785 10.1038/sj.bjp.0705667 2-s2.0-1842611884 (Pubitemid 38446178)
11. Cabral G. A., Staab A., Pertwee R. G., Effects on the immune system. Cannabinoids: Handbook of Experimental Pharmacology 2005 Heidelberg, Germany Springer 385 423
12. Ashton J. C., Milligan E. D., Cannabinoids for the treatment of neuropathic pain: clinical evidence. Current Opinion in Investigational Drugs 2008 9 1 65 75 2-s2.0-38049028807
13. Hosking R. D., Zajicek J. P., Therapeutic potential of cannabis in pain medicine. British Journal of Anaesthesia 2008 101 1 59 68 10.1093/bja/aen119 2-s2.0-45849135945 (Pubitemid 351881914)
14. Gertsch J., Leonti M., Raduner S., Racz I., Chen J., Xie X., Altmann K., Karsak M., Zimmer A., Beta-caryophyllene is a dietary cannabinoid. Proceedings of the National Academy of Sciences of the United States of America 2008 105 26 9099 9104 10.1073/pnas.0803601105 2-s2.0-48249115990
15. Bakr B., Him A., Özbek H., Düz E., Tütüncü M., Investigation of the anti-inflammatory and analgesic activities of β -caryophyllene. International Journal of Essential Oil Therapeutics 2008 2 41 44 (Pubitemid 351918052)
16. Klauke A. L., Racz I., Pradier B., Markert A., Zimmer A. M., Gertsch J., Zimmer A., The cannabinoid CB2 receptor-selective phytocannabinoid beta-caryophyllene exerts analgesic effects in mouse models of inflammatory and neuropathic pain. European Neuropsychopharmacology 2013 24 4 608 620 10.1016/j.euroneuro.2013.10.008
17. Zhang M. J., Spite M., Resolvins: anti-inflammatory and proresolving mediators derived from omega-3 polyunsaturated fatty acids. Annual Review of Nutrition 2012 32 203 227 10.1146/annurev-nutr-071811-150726 2-s2.0-84864252972
18. Bailes J. E., Mills J. D., Docosahexaenoic acid reduces traumatic axonal injury in a rodent head injury model. Journal of Neurotrauma 2010 27 9 1617 1624 10.1089/neu.2009.1239 2-s2.0-77957322763
19. Barros M. P., Marin D. P., Bolin A. P., De Cássia Santos Macedo R., Campoio T. R., Fineto C. Jr., Guerra B. A., Polotow T. G., Vardaris C., Mattei R., Otton R., Combined astaxanthin and fish oil supplementation improves glutathione-based redox balance in rat plasma and neutrophils. Chemico-Biological Interactions 2012 197 1 58 67 10.1016/j.cbi.2012.03.005 2-s2.0-84859496206
20. Zimmermann M., Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983 16 2 109 110 10.1016/0304-3959(83)90201-4 2-s2.0-0020525719 (Pubitemid 13058546)
21. Aloisi A. M., Ceccarelli I., Carlucci M., Suman A., Sindaco G., Mameli S., Paci V., Ravaioli L., Passavanti G., Bachiocco V., Pari G., Hormone replacement therapy in morphine-induced hypogonadic male chronic pain patients. Reproductive Biology and Endocrinology 2011 9, article 26 10.1186/1477-7827-9-26 2-s2.0-79951570486
22. de Maddalena C., Bellini M., Berra M., Meriggiola M. C., Aloisi A. M., Opioid-induced hypogonadism: why and how to treat it. Pain Physician 2012 15 3 ES111 ES118 2-s2.0-84871696877
23. 2 cannabinoid receptor-mediated peripheral antinociception. Pain 2001 93 3 239 245 10.1016/S0304-3959(01)00321-9 2-s2.0-0034886018 (Pubitemid 32763181)
24. Hervera A., Negrete R., Leánez S., Martín-Campos J., Pol O., The role of nitric oxide in the local antiallodynic and antihyperalgesic effects and expression of δ -opioid and cannabinoid-2 receptors during neuropathic pain in mice. Journal of Pharmacology and Experimental Therapeutics 2010 334 3 887 896 10.1124/jpet.110.167585 2-s2.0-77956244515
25. 2 cannabinoid receptor mediation of antinociception. Pain 2006 122 1-2 36 42 10.1016/j.pain.2005.12.018 2-s2.0-33646062552
26. Hanuš L., Breuer A., Tchilibon S., Shiloah S., Goldenberg D., Horowitz M., Pertwee R. G., Ross R. A., Mechoulam R., Fride E., HU-308: a specific agonist for CB2, a peripheral cannabinoid receptor. Proceedings of the National Academy of Sciences of the United States of America 1999 96 25 14228 14233 10.1073/pnas.96.25.14228 2-s2.0-12944263838 (Pubitemid 30000633)
27. Zimmer A., Racz I., Klauke A. L., Markert A., Gertsch J., Beta-caryophyllene, a phytocannabinoid acting on CB2 receptors. Proceedings of the 5th IACM Conference on Cannabinoids in Medicine October 2009 Cologne, Germany
28. Kimball E. S., Schneider C. R., Wallace N. H., Hornby P. J., Agonists of cannabinoid receptor 1 and 2 inhibit experimental colitis induced by oil of mustard and by dextran sulfate sodium. American Journal of Physiology: Gastrointestinal and Liver Physiology 2006 291 2 G364 G371 10.1152/ajpgi.00407. 2005 2-s2.0-33745783119 (Pubitemid 44024696)
29. Cole G. M., Frautschy S. A., DHA may prevent age-related dementia. Journal of Nutrition 2010 140 4 869 874 10.3945/jn.109.113910 2-s2.0-77949673613
30. Morris D. H., Methodologic challenges in designing clinical studies to measure differences in the bioequivalence of n-3 fatty acids. Molecular and Cellular Biochemistry 2003 246 1-2 83 90 10.1023/A:1023468315181 2-s2.0-0037741376 (Pubitemid 36798726)
31. Kumar V., Abbas A., Fausto N., Robbins and Cotran Pathologic Basis of Disease 2005 Philadelphia, Pa, USA W.B. Saunders
32. Ceccarelli I., Scaramuzzino A., Massafra C., Aloisi A. M., The behavioral and neuronal effects induced by repetitive nociceptive stimulation are affected by gonadal hormones in male rats. Pain 2003 104 1-2 35 47 10.1016/S0304- 3959(02)00460-8 2-s2.0-0038162238 (Pubitemid 36835872)
33. Aloisi A. M., Ceccarelli I., Fiorenzani P., Maddalena M., Rossi A., Tomei V., Sorda G., Danielli B., Rovini M., Cappelli A., Anzini M., Giordano A., Aromatase and 5-alpha reductase gene expression: modulation by pain and morphine treatment in male rats. Molecular Pain 2010 6, article 69 10.1186/1744-8069-6- 69 2-s2.0-77958145469
34. Gaumond I., Arsenault P., Marchand S., Specificity of female and male sex hormones on excitatory and inhibitory phases of formalin-induced nociceptive responses. Brain Research 2005 1052 1 105 111 10.1016/j.brainres.2005.06.011 2-s2.0-23644457656 (Pubitemid 41116292)
35. Saghaei E., Abbaszadeh F., Naseri K., Ghorbanpoor S., Afhami M., Haeri A., Rahimi F., Jorjani M., Estradiol attenuates spinal cord injury-induced pain by suppressing microglial activation in thalamic VPL nuclei of rats. Neuroscience Research 2013 75 4 316 323 10.1016/j.neures.2013.01.010 2-s2.0-84876159866
36. Ji R. R., Suter M. R., p38 MAPK, microglial signaling, and neuropathic pain. Molecular Pain 2007 3, article 33 10.1186/1744-8069-3-33 2-s2.0-38049119409